GSK Investigational Site

St.Peterburg 190103

0 studies enrolling now · 2 studies all time

What they study most

HIV Infections, Hepatitis C, Chronic, Infection, Human Immunodeficiency Virus

Studies at this site

• An Efficacy, Safety, and Tolerability Study Comparing Dolutegravir (DTG) Plus Lamivudine (3TC) With Dolutegravir Plus Tenofovir/Emtricitabine in Treatment naïve HIV Infected Participants (Gemini 2) — Completed
• Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Benefit Subjects With Hepatitis C Liver Disease — Completed